Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M. Fleischer, Hugh A. Sampson, Romain Lambert et al.|Journal of Allergy and Clinical Immunology|2020Cited by 101
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A. Pongracic, Philippe Bégin, Edmond S. Chan et al.|The Journal of Allergy and Clinical Immunology In Practice|2021Cited by 61
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow’s Milk AllergyDaniel Petroni, Robert A. Wood, Sayantani Sindher et al.|JAMA Pediatrics|2024Cited by 15